Study details
Enrolling now
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
University of Rochester
NCT IDNCT03739502ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
64
Study length
about 8.3 years
Ages
18–70
Locations
1 site in NY
What this study is about
This trial is testing whether hyperbaric oxygen can help with the process of engraftment after an umbilical cord blood stem cell transplant. It involves adults who have certain types of cancer, such as acute myeloid leukemia (AML), all types of lymphoma (NHL), Hodgkin disease, and myelodysplastic syndrome (MDS).
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Hyperbaric oxygen
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
VARIOUS
Body systems
Oncology